2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.
Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, Chapman MJ, De Backer GG, Delgado V, Ference BA, Graham IM, Halliday A, Landmesser U, Mihaylova B, Pedersen TR, Riccardi G, Richter DJ, Sabatine MS, Taskinen MR, Tokgozoglu L, Wiklund O; ESC Scientific Document Group.
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
Lifestyle factors and high-risk atherosclerosis: Pathways and mechanisms beyond traditional risk factors.
Lechner K, von Schacky C, McKenzie AL, Worm N, Nixdorff U, Lechner B, Kränkel N, Halle M, Krauss RM, Scherr J.
Eur J Prev Cardiol. 2020 Mar;27(4):394-406. doi: 10.1177/2047487319869400. Epub 2019 Aug 13.
Risk and protective factors of drug abuse among adolescents: a systematic review.
Nawi AM, Ismail R, Ibrahim F, Hassan MR, Manaf MRA, Amit N, Ibrahim N, Shafurdin NS.
BMC Public Health. 2021 Nov 13;21(1):2088. doi: 10.1186/s12889-021-11906-2.
Low risk chest pain? Make the negative a positive.
Zeitz C, Baumann A.
Med J Aust. 2022 Jul 4;217(1):28-29. doi: 10.5694/mja2.51599. Epub 2022 Jun 11.
Assessing Cardiovascular Risk in Patients with Diabetes: An Update.
Damaskos C, Garmpis N, Kollia P, Mitsiopoulos G, Barlampa D, Drosos A, Patsouras A, Gravvanis N, Antoniou V, Litos A, Diamantis E.
Curr Cardiol Rev. 2020;16(4):266-274. doi: 10.2174/1573403X15666191111123622.
When Low-Risk Atrial Fibrillation Is Not So Low Risk: Beast of Burden.
Steinberg BA, Piccini JP.
JAMA Cardiol. 2018 Jul 1;3(7):558-560. doi: 10.1001/jamacardio.2018.1205.
Could Patients At Low Cardiovascular Risk Be Better Stratified?
Fonseca FAH, Izar MC.
Arq Bras Cardiol. 2023 Jun;120(6):e20230310. doi: 10.36660/abc.20230310.
Risk factors for prolonged grief symptoms: A systematic review and meta-analysis.
Buur C, Zachariae R, Komischke-Konnerup KB, Marello MM, Schierff LH, O'Connor M.
Clin Psychol Rev. 2024 Feb;107:102375. doi: 10.1016/j.cpr.2023.102375. Epub 2023 Dec 29.
Communicating about risk: strategies for situations where public concern is high but the risk is low.
Hooker C, Capon A, Leask J.
Public Health Res Pract. 2017 Jan 15;27(1):2711709. doi: 10.17061/phrp2711709.
Targeted proteomics improves cardiovascular risk prediction in secondary prevention.
Nurmohamed NS, Belo Pereira JP, Hoogeveen RM, Kroon J, Kraaijenhof JM, Waissi F, Timmerman N, Bom MJ, Hoefer IE, Knaapen P, Catapano AL, Koenig W, de Kleijn D, Visseren FLJ, Levin E, Stroes ESG.
Eur Heart J. 2022 Apr 19;43(16):1569-1577. doi: 10.1093/eurheartj/ehac055.
